Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Net Margin (2016 - 2026)

Healthequity has reported Net Margin over the past 14 years, most recently at 14.87% for Q1 2026.

  • For Q1 2026, Net Margin rose 641.0% year-over-year to 14.87%; the TTM value through Jan 2026 reached 16.39%, up 833.0%, while the annual FY2026 figure was 16.38%, 832.0% up from the prior year.
  • Net Margin for Q1 2026 was 14.87% at Healthequity, down from 16.06% in the prior quarter.
  • Over five years, Net Margin peaked at 18.37% in Q3 2025 and troughed at 16.14% in Q1 2022.
  • A 5-year average of 5.36% and a median of 5.89% in 2023 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: tumbled -1900bps in 2022 and later soared 1605bps in 2023.
  • Year by year, Net Margin stood at 0.76% in 2022, then skyrocketed by 875bps to 5.89% in 2023, then tumbled by -68bps to 1.9% in 2024, then skyrocketed by 746bps to 16.06% in 2025, then dropped by -7bps to 14.87% in 2026.
  • Business Quant data shows Net Margin for HQY at 14.87% in Q1 2026, 16.06% in Q4 2025, and 18.37% in Q3 2025.